/Investor DB

Talis Capital — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Monomermonomerbio.cominJan 2024 · $5.6M

Monomer Bio builds software and automation solutions for biological research and development, serving research labs and biotech companies.

AI & Machine LearningBiotechData & InfrastructureDeep TechSaaS

Jimmy(CEO & Co-founder)Mark(Co-founder & Advisor)Yang(CTO)

Co-investorsLifeX Ventures

Zylonzylon.aiin𝕏Feb 2024

Zylon is a private, on-premise enterprise AI platform designed for organizations in regulated industries that need to deploy generative AI without sending sensitive data to public cloud providers.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaS

Iván Martínez Toro(Founder)in

Co-investorsFelicis VenturesLifeX VenturesZypsy Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.